These models would enable the isolation of the mutant PAH, determination of its molecular weight, assessment of its catalytic activity, and potentially the resolution of its three-dimensional structure by crystallographic methods, ultimately aiming to elucidate the functional impact of this duplication in the clinical context of PKU and HPA. This evidence concerns the gene HPSE and phenylketonuria.